JP2017513852A5 - - Google Patents

Download PDF

Info

Publication number
JP2017513852A5
JP2017513852A5 JP2016562874A JP2016562874A JP2017513852A5 JP 2017513852 A5 JP2017513852 A5 JP 2017513852A5 JP 2016562874 A JP2016562874 A JP 2016562874A JP 2016562874 A JP2016562874 A JP 2016562874A JP 2017513852 A5 JP2017513852 A5 JP 2017513852A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
independently
compound
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016562874A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017513852A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/025903 external-priority patent/WO2015160907A2/en
Publication of JP2017513852A publication Critical patent/JP2017513852A/ja
Publication of JP2017513852A5 publication Critical patent/JP2017513852A5/ja
Pending legal-status Critical Current

Links

JP2016562874A 2014-04-15 2015-04-15 C型肝炎ウイルスの強力及び選択的な阻害剤 Pending JP2017513852A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461980016P 2014-04-15 2014-04-15
US61/980,016 2014-04-15
PCT/US2015/025903 WO2015160907A2 (en) 2014-04-15 2015-04-15 Potent and selective inhibitors of hepatitis c virus

Publications (2)

Publication Number Publication Date
JP2017513852A JP2017513852A (ja) 2017-06-01
JP2017513852A5 true JP2017513852A5 (enExample) 2018-05-31

Family

ID=54324704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562874A Pending JP2017513852A (ja) 2014-04-15 2015-04-15 C型肝炎ウイルスの強力及び選択的な阻害剤

Country Status (14)

Country Link
US (1) US9926295B2 (enExample)
EP (1) EP3131892A4 (enExample)
JP (1) JP2017513852A (enExample)
KR (1) KR20170002407A (enExample)
CN (1) CN106661004A (enExample)
AU (1) AU2015247706A1 (enExample)
BR (1) BR112016023833A2 (enExample)
CA (1) CA2945514A1 (enExample)
IL (1) IL248318A0 (enExample)
MX (1) MX2016013434A (enExample)
PH (1) PH12016502039A1 (enExample)
RU (1) RU2016144076A (enExample)
SG (1) SG11201608587QA (enExample)
WO (1) WO2015160907A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717712B2 (en) 2013-07-02 2017-08-01 Bristol-Myers Squibb Company Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
JP2016527232A (ja) 2013-07-17 2016-09-08 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Hcvの治療に使用するためのビフェニル誘導体を含む組み合わせ
WO2015184644A1 (zh) * 2014-06-06 2015-12-10 爱博新药研发(上海)有限公司 抑制丙肝病毒的化合物、药物组合物及其应用
US10617675B2 (en) 2015-08-06 2020-04-14 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
CN112203652A (zh) * 2018-05-09 2021-01-08 共晶制药公司 用于治疗hcv的组合疗法
CN109456375B (zh) * 2018-12-11 2019-10-22 枣庄学院 一种抑制丙肝病毒的含单糖基杂环类化合物及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101492672B1 (ko) * 2008-02-13 2015-02-16 브리스톨-마이어스 스큅 컴퍼니 C형 간염 바이러스 억제제로서의 이미다졸릴 바이페닐 이미다졸
CA2751458C (en) * 2009-02-06 2018-06-05 Rfs Pharma, Llc Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
US8377980B2 (en) * 2009-12-16 2013-02-19 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
BR112013004520A2 (pt) * 2010-08-26 2016-06-07 Univ Emory inibidores potentes e seletivos do virus da hepatite c
WO2012048421A1 (en) * 2010-10-14 2012-04-19 Boehringer Ingelheim International Gmbh Hepatitis c inhibitor compounds
MX2013004906A (es) * 2010-11-01 2013-12-06 Genoscience Pharma Nuevos inhibidores especificos de la proteasa ns3 de hcv.

Similar Documents

Publication Publication Date Title
JP2019524883A5 (enExample)
JP2015520140A5 (enExample)
JP2015531773A5 (enExample)
JP2016503797A5 (enExample)
JP2016506958A5 (enExample)
JP2016518437A5 (enExample)
JP2018514518A5 (enExample)
JP2016540742A5 (enExample)
JP2016515560A5 (enExample)
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
JP2015500843A5 (enExample)
JP2014511892A5 (enExample)
JP2013537203A5 (enExample)
JP2014521688A5 (enExample)
JP2015143283A5 (enExample)
JP2017504635A5 (enExample)
RU2016150486A (ru) Ингибиторы бета-лактамазы
JP2016506369A5 (enExample)
JP2016500661A5 (enExample)
JP2020532585A5 (enExample)
JP2013544860A5 (enExample)
RU2016134751A (ru) Соединения
JP2017501237A5 (enExample)
JP2014530838A5 (enExample)
JP2019535723A5 (enExample)